Functional genomics: improving cancer prognosis and drug development.
Mariani
Sara M
SM
Medscape General Medicine.
D014408:Biomarkers, Tumor / Q000235:genetics; D001943:Breast Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics; D002460:Cell Line; D030541:Databases, Genetic; D018572:Disease-Free Survival; D015195:Drug Design; D005260:Female; D020869:Gene Expression Profiling; D015972:Gene Expression Regulation, Neoplastic / Q000235:genetics; D015894:Genome, Human; D023281:Genomics / Q000379:methods*; D018922:HL-60 Cells; D016045:Human Genome Project; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy / Q000201:enzymology / Q000235:genetics; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics; D009369:Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000235:genetics*; D020411:Oligonucleotide Array Sequence Analysis; D009928:Organ Specificity / Q000235:genetics; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy / Q000201:enzymology / Q000235:genetics; D011379:Prognosis; D014176:Protein Biosynthesis / Q000187:drug effects; D011493:Protein Kinase C / Q000235:genetics; D011518:Proto-Oncogene Proteins / Q000235:genetics; D020794:Receptor Protein-Tyrosine Kinases / Q000235:genetics; D051941:fms-Like Tyrosine Kinase 3
D014408:Biomarkers, Tumor; D011518:Proto-Oncogene Proteins; C497970:FLT3 protein, human; D020794:Receptor Protein-Tyrosine Kinases; D051941:fms-Like Tyrosine Kinase 3; D011493:Protein Kinase C